发明名称 USE OF CELL PERMEABLE PEPTIDIC INHIBITOR IN JNK SIGNAL TRANSMISSION PATH FOR THERAPY OF VARIOUS ILLNESSES
摘要 <p>PROBLEM TO BE SOLVED: To provide identification of a further disease capable of being cured with a JNK inhibitor peptide and use of a new JNK inhibitor peptide and a derivative thereof for therapy of the above-mentioned diseases and a disease unknown or already-known to be strongly related to JNK signal transmission.SOLUTION: For therapy of various diseases or disorders strongly related to JNK signal transmission, a protein kinase inhibitor, specifically a protein kinase c-Jun amino-terminal kinase inhibitor, a JNK inhibitor sequence, a chimeric peptide or a nucleic acid coding this, and a medicinal composition containing this are used. The diseases or disorders are selected from autoimmune diseases, cardiac diseases, cancer diseases, diabetes (including Type 1 or 2 diabete), inflammatory diseases, alopecia (including alopecia areata), lung diseases, neurologic diseases or neurodegenerative diseases, liver diseases, spinal diseases, uterus diseases, virus infection, and depression.</p>
申请公布号 JP2014111646(A) 申请公布日期 2014.06.19
申请号 JP20140029875 申请日期 2014.02.19
申请人 XIGEN INFLAMMATION LTD 发明人 BONNY CHRISTOPHE
分类号 A61K38/00;A61K48/00;A61P1/16;A61P3/10;A61P9/00;A61P11/00;A61P15/00;A61P17/14;A61P21/02;A61P25/00;A61P25/04;A61P25/16;A61P25/24;A61P25/28;A61P27/02;A61P29/00;A61P31/04;A61P31/12;A61P31/16;A61P31/18;A61P33/06;A61P35/00;A61P35/02;A61P37/02;A61P37/06;A61P43/00;C07K14/00;C12N15/09 主分类号 A61K38/00
代理机构 代理人
主权项
地址